Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability [version 2; peer review: 2 approved]
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling side effect of various chemotherapeutic agents, including oxaliplatin. It is highly prevalent amongst cancer patients, causing sensory abnormalities and pain. Unfortunately, as the underlying mechanisms remain poorly unders...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wellcome
2021-06-01
|
Series: | Wellcome Open Research |
Online Access: | https://wellcomeopenresearch.org/articles/6-68/v2 |
id |
doaj-d41b23d9cad04225ac62af594281b6ea |
---|---|
record_format |
Article |
spelling |
doaj-d41b23d9cad04225ac62af594281b6ea2021-07-05T13:10:26ZengWellcomeWellcome Open Research2398-502X2021-06-01610.12688/wellcomeopenres.16635.218722Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability [version 2; peer review: 2 approved]Zoe Lee Hore0Sara Villa-Hernandez1Franziska Denk2Wolfson Centre for Age-Related Diseases, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE1 1UL, UKWolfson Centre for Age-Related Diseases, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE1 1UL, UKWolfson Centre for Age-Related Diseases, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE1 1UL, UKBackground: Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling side effect of various chemotherapeutic agents, including oxaliplatin. It is highly prevalent amongst cancer patients, causing sensory abnormalities and pain. Unfortunately, as the underlying mechanisms remain poorly understood, effective therapeutics are lacking. Neuro-immune interactions have been highlighted as potential contributors to the development and maintenance of CIPN, however, whether this is the case in oxaliplatin-induced peripheral neuropathy (OIPN) is yet to be fully established. Methods: In this study we used flow cytometry to examine the peripheral immune response of male C57BL/6 mice following both single and repeated oxaliplatin administration. In animals exposed to repeated dosing, we also undertook mechanical and thermal behavioural assays to investigate how oxaliplatin alters phenotype, and conducted RT-qPCR experiments on bone marrow derived macrophages in order to further inspect the effects of oxaliplatin on immune cells. Results: In contrast to other reports, we failed to observe substantial changes in overall leukocyte, lymphocyte or myeloid cell numbers in dorsal root ganglia, sciatic nerves or inguinal lymph nodes. We did however note subtle, tissue-dependant alterations in several myeloid subpopulations following repeated dosing. These included a significant reduction in MHCII antigen presenting cells in the sciatic nerve and an increase in infiltrating cell types into the inguinal lymph nodes. Though repeated oxaliplatin administration had a systemic effect, we were unable to detect a pain-like behavioural phenotype in response to either cold or mechanical stimuli. Consequently, we cannot comment on whether the observed myeloid changes are associated with OIPN. Conclusions: Our discussion puts these results into the wider context of the field, advocating for greater transparency in reporting, alignment in experimental design and the introduction of more clinically relevant models. Only through joint concerted effort can we hope to increase our understanding of the underlying mechanisms of CIPN, including any immune contributions.https://wellcomeopenresearch.org/articles/6-68/v2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zoe Lee Hore Sara Villa-Hernandez Franziska Denk |
spellingShingle |
Zoe Lee Hore Sara Villa-Hernandez Franziska Denk Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability [version 2; peer review: 2 approved] Wellcome Open Research |
author_facet |
Zoe Lee Hore Sara Villa-Hernandez Franziska Denk |
author_sort |
Zoe Lee Hore |
title |
Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability [version 2; peer review: 2 approved] |
title_short |
Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability [version 2; peer review: 2 approved] |
title_full |
Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability [version 2; peer review: 2 approved] |
title_fullStr |
Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability [version 2; peer review: 2 approved] |
title_full_unstemmed |
Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability [version 2; peer review: 2 approved] |
title_sort |
probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability [version 2; peer review: 2 approved] |
publisher |
Wellcome |
series |
Wellcome Open Research |
issn |
2398-502X |
publishDate |
2021-06-01 |
description |
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling side effect of various chemotherapeutic agents, including oxaliplatin. It is highly prevalent amongst cancer patients, causing sensory abnormalities and pain. Unfortunately, as the underlying mechanisms remain poorly understood, effective therapeutics are lacking. Neuro-immune interactions have been highlighted as potential contributors to the development and maintenance of CIPN, however, whether this is the case in oxaliplatin-induced peripheral neuropathy (OIPN) is yet to be fully established. Methods: In this study we used flow cytometry to examine the peripheral immune response of male C57BL/6 mice following both single and repeated oxaliplatin administration. In animals exposed to repeated dosing, we also undertook mechanical and thermal behavioural assays to investigate how oxaliplatin alters phenotype, and conducted RT-qPCR experiments on bone marrow derived macrophages in order to further inspect the effects of oxaliplatin on immune cells. Results: In contrast to other reports, we failed to observe substantial changes in overall leukocyte, lymphocyte or myeloid cell numbers in dorsal root ganglia, sciatic nerves or inguinal lymph nodes. We did however note subtle, tissue-dependant alterations in several myeloid subpopulations following repeated dosing. These included a significant reduction in MHCII antigen presenting cells in the sciatic nerve and an increase in infiltrating cell types into the inguinal lymph nodes. Though repeated oxaliplatin administration had a systemic effect, we were unable to detect a pain-like behavioural phenotype in response to either cold or mechanical stimuli. Consequently, we cannot comment on whether the observed myeloid changes are associated with OIPN. Conclusions: Our discussion puts these results into the wider context of the field, advocating for greater transparency in reporting, alignment in experimental design and the introduction of more clinically relevant models. Only through joint concerted effort can we hope to increase our understanding of the underlying mechanisms of CIPN, including any immune contributions. |
url |
https://wellcomeopenresearch.org/articles/6-68/v2 |
work_keys_str_mv |
AT zoeleehore probingtheperipheralimmuneresponseinmousemodelsofoxaliplatininducedperipheralneuropathyhighlightstheirlimitedtranslatabilityversion2peerreview2approved AT saravillahernandez probingtheperipheralimmuneresponseinmousemodelsofoxaliplatininducedperipheralneuropathyhighlightstheirlimitedtranslatabilityversion2peerreview2approved AT franziskadenk probingtheperipheralimmuneresponseinmousemodelsofoxaliplatininducedperipheralneuropathyhighlightstheirlimitedtranslatabilityversion2peerreview2approved |
_version_ |
1721318566410584064 |